Genomics & CRISPR Market Overview

According to MarketGenics, the global Genomics & CRISPR Market was valued at USD 27.4 billion in 2025 and is projected to reach USD 134 billion by 2035, registering a CAGR of 17.2% during the forecast period (2025–2035). The market is witnessing remarkable growth due to rapid advancements in genome sequencing, gene-editing technologies, precision medicine, and molecular diagnostics. Genomics and CRISPR technologies are revolutionizing biomedical research by enabling scientists to understand genetic diseases, develop targeted therapies, improve agricultural biotechnology, and accelerate drug discovery. Increasing investments in genomics research, expanding applications of CRISPR-Cas gene-editing systems, and the growing adoption of next-generation sequencing (NGS) technologies are driving market expansion. Furthermore, rising demand for personalized medicine, regenerative therapies, and genetic testing, coupled with supportive government funding and biotechnology innovation, is expected to fuel long-term market growth.

To obtain a free sample research report - https://marketgenics.co/download-report-sample/genomics-crispr-market-59691

Market Growth Drivers

The Genomics & CRISPR Market is primarily driven by the increasing prevalence of genetic disorders, cancer, rare diseases, and chronic illnesses that require advanced genomic analysis and precision treatment approaches. The growing adoption of next-generation sequencing (NGS), CRISPR-Cas9 gene editing, single-cell genomics, and molecular diagnostics is enabling researchers and healthcare providers to develop more accurate diagnostic tools and targeted therapies. Significant investments by pharmaceutical companies, biotechnology firms, academic institutions, and government organizations are accelerating innovation in gene editing, cell therapy, and regenerative medicine. In addition, the commercialization of CRISPR-based therapeutics, advancements in synthetic biology, AI-powered genomic analysis, and expanding clinical trials are creating substantial market opportunities. Increasing demand for agricultural genomics, livestock breeding, and industrial biotechnology applications is also contributing to market growth beyond healthcare.

Key Players

The Genomics & CRISPR Market is highly competitive, with leading biotechnology companies, genomics solution providers, and pharmaceutical organizations investing heavily in gene-editing technologies and precision medicine. Major players include:

• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• QIAGEN N.V.
• PacBio (Pacific Biosciences)
• Oxford Nanopore Technologies
• CRISPR Therapeutics AG
• Editas Medicine
• Intellia Therapeutics
• Beam Therapeutics
• Vertex Pharmaceuticals Incorporated
• 10x Genomics
• Agilent Technologies
• Bio-Rad Laboratories
• Merck KGaA

These companies are focusing on next-generation sequencing platforms, CRISPR-based therapeutics, AI-powered genomic analytics, molecular diagnostics, and strategic collaborations to strengthen their leadership in the genomics ecosystem.

Regional Insights

North America dominates the Genomics & CRISPR Market due to strong biotechnology infrastructure, advanced healthcare systems, significant R&D investments, and the presence of leading genomics and pharmaceutical companies. The United States accounts for the largest market share, supported by government funding, expanding precision medicine initiatives, and rapid commercialization of gene-editing technologies. Europe remains another significant market, driven by increasing genomics research, favorable regulatory support, and biotechnology innovation across Germany, the United Kingdom, France, Switzerland, and the Netherlands. Asia-Pacific is expected to witness the fastest growth during the forecast period, fueled by expanding biotechnology investments, government genomics programs, increasing genetic testing, and growing healthcare infrastructure across China, Japan, South Korea, India, Singapore, and Australia. Emerging markets in the Middle East and Latin America are also investing in genomic medicine, biotechnology research, and healthcare innovation.

Future Outlook

According to MarketGenics, the future of the Genomics & CRISPR Market will be driven by continuous advancements in gene editing, synthetic biology, AI-powered genomics, and precision medicine. Emerging technologies such as base editing, prime editing, CRISPR diagnostics, spatial genomics, single-cell sequencing, and multi-omics analysis are expected to transform disease diagnosis and treatment. Increasing commercialization of gene therapies, expansion of personalized medicine, regenerative medicine applications, and AI-assisted genomic interpretation will further accelerate market growth. Strategic collaborations among biotechnology companies, pharmaceutical manufacturers, academic research institutes, and healthcare providers will continue to drive innovation and clinical adoption. As genomic technologies become more affordable and accessible, genomics and CRISPR are expected to play a transformative role in healthcare, agriculture, industrial biotechnology, and life sciences research worldwide.

Related Reports:

Digital Therapeutics (DTX) Market

Short Bowel Syndrome Market

Pancreatic Cancer Treatment Market

Orthodontics Market

Satellite Data Services Market

Contact:
Mr. Debashish Roy
MarketGenics Global Research
800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States
USA: +1 (302) 303-2617
Email: sales@marketgenics.co
Website: https://marketgenics.co